He came to Northwestern from the University of California, San Francisco where he was vice chairman of the department of neurological surgery and spearheaded a new approach for brain cancer treatment. He removed patient tumors and created individual vaccines from malignant masses.
Dr. Parsa’s methodology is in the third phase of clinical trials at Northwestern, where he was also leading a trial to test surgery technology for more safe rare brain tumor removal. He also performed around 300 surgeries per year and authored more than 300 publications. Dr. Parsa was on the board of several medical organizations and completed his medical degree at SUNY Downstate Medical Center in Brooklyn.
The cause of death has not been released. Dr. Parsa was 48 years old.
Dr. Parsa’s wife is an associate professor of orthopedic surgery at Northwestern and he has three children.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
